May 2, 2018 / 11:21 AM / 22 days ago

BRIEF-Akcea Announces Expansion of Global Early Access Program to Provide Volanesorsen to People Living with FCS

May 2 (Reuters) - Akcea Therapeutics Inc:

* AKCEA THERAPEUTICS - EXPANDED GLOBAL EARLY ACCESS PROGRAM TO U.S. TO PROVIDE VOLANESORSEN TO PEOPLE LIVING WITH FAMILIAL CHYLOMICRONEMIA SYNDROME (FCS) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below